Stocks to Watch Today (Sep 11): Vodafone Idea, Neogen Chemicals, KIMS, Granules India and more
NiveshIQ
NSE: KIMS · Healthcare
Krishna Institute of Medical Sciences Ltd.
₹768.95▼ ₹3.85 (-0.50%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on KIMS. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Krishna Institute of Medical Sciences Ltd.
Krishna Institute of Medical Sciences Limited (KIMS) is a leading healthcare services provider in India, operating under the KIMS Hospitals brand. The company offers a wide range of medical services, including cardiology, oncology, neurology, and orthopedics, among others. KIMS Hospitals reported a 36% year-over-year (YoY) increase in revenue to ₹1,196 crore in Q1 FY27, with a net profit of ₹37 crore. The company's revenue for the last reported fiscal year stood at ₹4,213 crore, with a net income of ₹204 crore. KIMS Hospitals has a strong competitive position in the Indian healthcare market, with a large network of hospitals and a diverse range of services. The company's growth outlook is positive, driven by increasing demand for healthcare services in India and its expanding network of ho
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹2,498 Cr +13.60% | ₹3,035 Cr +21.50% | ₹3,905 Cr +28.70% |
| EBITDA Margin | 25.94% | 26.13% | 21.21% |
| Net Profit | ₹336.00 Cr -8.20% | ₹415.00 Cr +23.50% | ₹242.00 Cr -41.70% |
| EPS | ₹7.75 | ₹9.61 | ₹6.03 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Stocks to Watch Today (Sep 11): Vodafone Idea, Neogen Chemicals, KIMS, Granules India and more
Top stocks in focus tomorrow: Investors must watch Fino Payments, KIMS, Texmaco Rail shares on Fri, 11 Sept | Triggers
🔒
+ 3 more stories about Krishna Institute of Medical Sciences Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹1, 180 Cr, PAT ₹37 Cr, EPS ₹1.04, EBITDA margin 20.3%. Growth context: revenue YoY +776.1%, PAT YoY -66.7%, revenue QoQ +9.8%, PAT QoQ +13.0%. Street verdict: strong miss, revenue surprise +2.7%, PAT surprise -36.8%.
Key drivers for KIMS over the next 2–4 quarters remain test volumes, test mix, B2B/reference-lab traction, pricing disci...
In FY26, KIMS reported revenue of ₹3, 905 Cr, PAT of ₹242 Cr, an EBITDA margin of 21.2%, and EPS of ₹6.03, with year-on-...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for KIMS
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track KIMS alongside your other holdings
Unlock full KIMS research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Krishna Institute of Medical Sciences Ltd.?
NiveshIQ detects active intelligence signals for Krishna Institute of Medical Sciences Ltd. (KIMS) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Krishna Institute of Medical Sciences Ltd.?
Krishna Institute of Medical Sciences Ltd. operates in the Healthcare sector with a market capitalisation of ₹2,868,996.3L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.